FINWIRES · TerminalLIVE
FINWIRES

Caliway Biopharmaceuticals Seeks US FDA Nod for Fat Reduction Drug Trial

By

Caliway Biopharmaceuticals (TPE:6919) submitted an investigational new drug application for a phase 2 clinical trial of CBL-0201WR to the U.S. Food and Drug Administration (FDA).

The company aims to study the product in combination with tirzepatide to reduce abdominal subcutaneous fat in overweight or obese adults, according to a Monday Taiwan bourse filing.

The company expects to enroll 120 subjects for the trial in the U.S.

CBL-0201WR is indicated for subcutaneous fat reduction, treating moderate to severe cellulite, and Dercum's Disease.

Related Articles

Asia

Cauldron Energy Receives Further Passive Seismic Interpretations at Yanrey Uranium Project; Shares Down 7%

Cauldron Energy (ASX:CXU) said Southern Geoscience has provided a further installment of processed passive seismic interpretations for its Yanrey Uranium Project in Western Australia, covering the Manyingee Southeast, Manyingee West, Ashburton East and Cosgrove locations, according to a Monday Australian bourse filing.The company said the most significant finding from the third installment is the delineation of a separate, previously undiscovered and untested arm of the Manyingee South palaeochannel, with passive seismic continuing to prove a cost-effective method for identifying the margins of palaeochannels and increasing drilling effectiveness.The company's shares fell almost 7% in recent Monday trade.

ASX:CXU
Asia

Infoline Tec Group Seeks Shareholder Nod to Acquire Buildings for New Head Office

Infoline Tec Group (KLSE:INFOTEC) is seeking shareholders' approval for its wholly-owned subsidiary, Infoline IT Solutions, to acquire two adjoining intermediate units from Huayi (SEA) and Orionis Technology, respectively, for a total of 18.6 Malaysian ringgit, according to a Monday filing to Bursa Malaysia.The investor approval will be sought at the upcoming extraordinary general meeting on Aug. 28.The company's shares were down nearly 6% in recent trade.The acquired units will be used to set up the company's new head office. Both acquisitions will be done on a 99-year lease up to Oct. 18, 2106.Infoline's board is also seeking shareholders' nod for a proposed employees' share option scheme (ESOS) covering up to 10% of issued share capital for eligible directors and employees. The scheme will be valid for five years with an option for a further five-year extension.

KLSE:INFOTEC
Asia

Hanwha Aerospace Secures Framework Supply Contract in South Korea

Hanwha Aerospace (KRX:012450) secured a framework contract with an unnamed entity to supply aerospace products, exceeding 2.5% of its most recent annual sales, according to a Monday filing with the Korea Exchange.The company said that the contract is subject to disclosure requirements, and the details of the agreement are withheld due to business confidentiality.

KRX:012450